Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier M Bertina

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|May 5, 2006
The constitutive expression of anticoagulant protein S is regulated through multiple binding sites for Sp1 and Sp3 transcription factors in the protein S gene promoterCornelia J F de Wolf, Rosemiek M J Cupers, Rogier M Bertina, et al.
Thrombosis and Haemostasis|February 28, 2002
The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factorJeroen C J Eikenboom, Giancarlo Castaman, Pieter W Kamphuisen, et al.
British Journal of Haematology|August 16, 2002
The effect of plasma caeruloplasmin levels on the sensitivity for activated protein CMarieke C H de Visser, John H M Souverijn, Frits R Rosendaal, et al.
Blood|February 1, 2003
Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosisAnders Dahm, Astrid Van Hylckama Vlieg, Bjorn Bendz, et al.
British Journal of Haematology|July 26, 2002
Protein C inhibitor (plasminogen activator inhibitor-3) and the risk of venous thrombosisJoost C M Meijers, J Arnoud Marquart, Rogier M Bertina, et al.
European Journal of Human Genetics : EJHG|April 1, 2004
Candidate gene approach in association studies: would the factor V Leiden mutation have been found by this approach?Astrid van Hylckama Vlieg, Lodewijk A Sandkuijl, Frits R Rosendaal, et al.
The Journal of Biological Chemistry|December 9, 2003
Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679Marijn van der Neut Kolfschoten, Richard J Dirven, Hans L Vos, et al.
Thrombosis and Haemostasis|January 26, 2012
Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levelsPilar Medina, Elena Bonet, Silvia Navarro, et al.
Blood|June 22, 2014
Fibrinogen γ' increases the sensitivity to activated protein C in normal and factor V Leiden plasmaFarida Omarova, Shirley Uitte de Willige, Paolo Simioni, et al.
Haematologica|April 12, 2008
Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutationSilvia Navarro, Pilar Medina, Yolanda Mira, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|May 5, 2006
The constitutive expression of anticoagulant protein S is regulated through multiple binding sites for Sp1 and Sp3 transcription factors in the protein S gene promoterCornelia J F de Wolf, Rosemiek M J Cupers, Rogier M Bertina, et al.
Thrombosis and Haemostasis|February 28, 2002
The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factorJeroen C J Eikenboom, Giancarlo Castaman, Pieter W Kamphuisen, et al.
British Journal of Haematology|August 16, 2002
The effect of plasma caeruloplasmin levels on the sensitivity for activated protein CMarieke C H de Visser, John H M Souverijn, Frits R Rosendaal, et al.
Blood|February 1, 2003
Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosisAnders Dahm, Astrid Van Hylckama Vlieg, Bjorn Bendz, et al.
British Journal of Haematology|July 26, 2002
Protein C inhibitor (plasminogen activator inhibitor-3) and the risk of venous thrombosisJoost C M Meijers, J Arnoud Marquart, Rogier M Bertina, et al.
European Journal of Human Genetics : EJHG|April 1, 2004
Candidate gene approach in association studies: would the factor V Leiden mutation have been found by this approach?Astrid van Hylckama Vlieg, Lodewijk A Sandkuijl, Frits R Rosendaal, et al.
The Journal of Biological Chemistry|December 9, 2003
Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679Marijn van der Neut Kolfschoten, Richard J Dirven, Hans L Vos, et al.
Thrombosis and Haemostasis|January 26, 2012
Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levelsPilar Medina, Elena Bonet, Silvia Navarro, et al.
Blood|June 22, 2014
Fibrinogen γ' increases the sensitivity to activated protein C in normal and factor V Leiden plasmaFarida Omarova, Shirley Uitte de Willige, Paolo Simioni, et al.
Haematologica|April 12, 2008
Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutationSilvia Navarro, Pilar Medina, Yolanda Mira, et al.
Pageof 5